Extracellular vesicles (EVs) have rapidly emerged as one of the most promising frontiers in modern biology. These nano-sized messengers mediate communication between cells, tissues, and organs, ...

A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

We’re back with our roundup of the most insightful studies of the year, from the power of brain breaks to groundbreaking ...

Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial proteomics and lipidomics easier to use – no coding required. C-COMPASS ...

A study from the Hospital del Mar Research Institute, published in The Journal of Clinical Investigation, indicates that the high expression of the estrogen receptor is the main factor preventing the ...

Gordon Freeman, Harvard Medical School professor of medicine at Dana-Farber Cancer Institute, and Arlene Sharpe, the ...

Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in its Phase I/II clinical trial evaluating ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

For super-resolution microscopes, AI helps by restoring images from even noisy, low-fluorescence data. That capability helps ...